Abstract
Background: The pandemic of Coronavirus disease 2019 (COVID-19) represented a scientific and social crisis. Among the most pressing unmet needs for coronavirus disease in 2019 was its unpredictable clinical course, which resulted in an irreversible outcome. The presence of post-acute COVID-19 syndrome in survivors, as well as the exploration of different blood cell counts in Covid 19 survivors, seems to be unclear, and scientific data is still being summarized. Patients can be divided into three categories: mild, moderate, and severe in terms of infection severity. Platelets, white blood cell total count, lymphocytes, neutrophils and hemoglobin levels have all been linked to COVID-19 infection and severity. In this regard, evaluation of hematological abnormalities at the beginning, during and after COVID-19 infection and during COVID-19 that can be indicative of prognosis in the recovery phase. The purpose of this study was to analyze the complete blood picture among COVID-19 survivors & co-relate it with disease severity which can be implemented as a prognostic biomarker of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
